Cargando…
Daily Nutritional Supplementation with Vitamin D(3) and Phenylbutyrate to Treatment-Naïve HIV Patients Tested in a Randomized Placebo-Controlled Trial
Poor nutritional status is common among human immunodeficiency virus (HIV)-infected patients including vitamin D (vitD(3)) deficiency. We conducted a double-blinded, randomized, and placebo-controlled trial in Addis Ababa, Ethiopia, to investigate if daily nutritional supplementation with vitD(3) (5...
Autores principales: | Ashenafi, Senait, Amogne, Wondwossen, Kassa, Endale, Gebreselassie, Nebiat, Bekele, Amsalu, Aseffa, Getachew, Getachew, Meron, Aseffa, Abraham, Worku, Alemayehu, Hammar, Ulf, Bergman, Peter, Aderaye, Getachew, Andersson, Jan, Brighenti, Susanna |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6356462/ https://www.ncbi.nlm.nih.gov/pubmed/30634590 http://dx.doi.org/10.3390/nu11010133 |
Ejemplares similares
-
Vitamin D and Phenylbutyrate Supplementation Does Not Modulate Gut Derived Immune Activation in HIV-1
por: Missailidis, Catharina, et al.
Publicado: (2019) -
Anemia Is a Strong Predictor of Wasting, Disease Severity, and Progression, in Clinical Tuberculosis (TB)
por: Ashenafi, Senait, et al.
Publicado: (2022) -
Vitamin D(3) Status and the Association with Human Cathelicidin Expression in Patients with Different Clinical Forms of Active Tuberculosis
por: Ashenafi, Senait, et al.
Publicado: (2018) -
BCG-specific IgG-secreting peripheral plasmablasts as a potential biomarker of active tuberculosis in HIV negative and HIV positive patients
por: Ashenafi, Senait, et al.
Publicado: (2013) -
Immunosuppressive Features of the Microenvironment in Lymph Nodes Granulomas from Tuberculosis and HIV–Co-Infected Patients
por: Ashenafi, Senait, et al.
Publicado: (2022)